Gimv is a European investment company listed on Euronext Brussels since 1997 and manages about 1.1 billion EUR invested in about 55 portfolio companies as of 2019. Gimv invests in four main investment platforms which are Connected Consumer, Health and Care, Smart Industries and Sustainable Cities. The company has four home markets which are Belgium, Netherlands, France and DACH (Germany (D), Austria and Switzerland (CH).
Timeline
Funding Rounds Participated In
Invested in
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Nick Paul
September 15, 2021
FierceBiotech
In 2017, Joël de Beer dropped out of his Ph.D. program and began trying to build a leading genetic medicines company from a site the size of a parking space. After working quietly for several years to realize the vision, de Beer's Anjarium Biosciences has now broken cover with 55.5 million Swiss francs from top-tier investors including Abingworth, Gimv and Pfizer Ventures.
References
Venture capital firm
CompanyCompany attributes
Industry
Venture capital
Belgium
AntwerpCrunchbase
Founded date
February 25, 1980
